Skip to main content

12:00 PM Central | 1:00 PM Eastern | 11:00 AM Mountain | 10:00 AM Pacific | 9:00 AM Alaska | 7:00 AM Hawaii-Aleutian

Duration: 90 Minutes

Target Audience: Compliance professionals, diversion specialists, and healthcare executives

Learning Objectives:

  • Identify one change in DEA rules due to COVID-19
  • Describe at least two workflow changes during COVID-19 that created unintended opportunities for diversion
  • Relate human responses to COVID-19 and impact on rate of drug diversion in healthcare
  • Evaluate three drug diversion risk mitigation strategies



Member Rate


Non Member Rate  


Registration + First-Time Membership


*Save by joining today (first-time members only). Dues renew at $325.
Can't Attend? Purchase the 
Recordings will be emailed 1-3 business days after the initial air date.
CD-ROM recordings available upon special request. 
Interested in speaking at an HCCA web conference? 
Apply Today